NASDAQ:ONTX
Onconova Therapeutics Stock News
$1.00
+0 (+0%)
At Close: Apr 25, 2024
Onconova Therapeutics to Present at NobleCon19, Noble Capital Markets' Nineteenth Annual Emerging Growth Equity Conference
08:00am, Tuesday, 28'th Nov 2023
NEWTOWN, Pa., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”, the “Company”), a clinical-stage biopharmaceutical company focused on discovering and d
Onconova Therapeutics, Inc. (ONTX) Q3 2023 Earnings Call Transcript
08:18pm, Tuesday, 14'th Nov 2023
Onconova Therapeutics, Inc. (NASDAQ:ONTX ) Q3 2023 Earnings Conference Call November 14, 2023 4:30 PM ET Company Participants Bruce Mackle - LifeSci Advisors, IR Steve Fruchtman - President and CEO Vi
Onconova Therapeutics to Provide Corporate Update and Announce Third Quarter 2023 Financial Results on November 14, 2023
04:05pm, Tuesday, 07'th Nov 2023
NEWTOWN, Pa., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova” or “the Company”), a clinical-stage biopharmaceutical company focused on discovering and
Onconova Therapeutics to Present a Late-Breaking Abstract on Rigosertib at the 2023 EADV Congress
08:00am, Thursday, 28'th Sep 2023
NEWTOWN, Pa., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”, the “Company”), a clinical-stage biopharmaceutical company focused on discovering and
Onconova Therapeutics, Inc. (ONTX) Q2 2023 Earnings Call Transcript
09:08pm, Thursday, 10'th Aug 2023
Onconova Therapeutics, Inc. (NASDAQ:ONTX ) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Bruce Mackle - LifeSci Advisors, IR Dr. Steve Fruchtman - President and CEO
Onconova Therapeutics, Inc. (ONTX) Q1 2023 Earnings Call Transcript
09:11pm, Monday, 15'th May 2023
Onconova Therapeutics, Inc. (NASDAQ:ONTX ) Q1 2023 Earnings Conference Call May 15, 2023 4:30 PM ET Company Participants Bruce Mackle - Managing Director, LifeSci Advisors Steven Fruchtman - President
Onconova Therapeutics, Inc. (ONTX) Reports Q1 Loss, Misses Revenue Estimates
06:59pm, Monday, 15'th May 2023
Onconova Therapeutics, Inc. (ONTX) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.20 per share a year ago.
Onconova Therapeutics to Provide Corporate Update and Announce First Quarter 2023 Financial Results on May 15, 2023
04:05pm, Thursday, 04'th May 2023
Company to host conference call and webcast at 4:30 p.m. ET on Monday, May 15, 2023 Company to host conference call and webcast at 4:30 p.m. ET on Monday, May 15, 2023
3 Penny Stocks To Buy According To Analysts, Targets Up To 1,029%
11:28am, Tuesday, 25'th Apr 2023
Analysts say these are penny stocks to buy but do you agree? The post 3 Penny Stocks To Buy According To Analysts, Targets Up To 1,029% appeared first on Penny Stocks to Buy, Picks, News and Informati
5 Hot Penny Stocks To Watch With The Stock Market Down This Week
01:15pm, Monday, 24'th Apr 2023
Hot penny stocks to watch this week. This is a significant week for earnings, and mega-cap tech names will headline what's sure to be a volatile week. Next week, the action continues with the upcoming
Penny Stocks To Buy Now? 5 With Big News Today
10:22am, Friday, 21'st Apr 2023
Penny stocks news sparks momentum in the stock market today. The post Penny Stocks To Buy Now?
Onconova Therapeutics, Inc. (ONTX) Q4 2022 Earnings Call Transcript
09:56pm, Thursday, 16'th Mar 2023
Onconova Therapeutics, Inc. (NASDAQ:ONTX ) Q4 2022 Earnings Conference Call March 16, 2023 4:30 PM ET Company Participants Bruce Mackle - LifeSci Advisors Steven Fruchtman - CEO, President & Director
Onconova Therapeutics to Provide Corporate Update and Announce Fourth Quarter and Full Year 2022 Financial Results on March 16, 2023
04:05pm, Thursday, 09'th Mar 2023
Company to host conference call and webcast at 4:30 p.m. ET on Thursday, March 16, 2023 Company to host conference call and webcast at 4:30 p.m. ET on Thursday, March 16, 2023
Onconova Therapeutics to Present at the Upcoming MedInvest Oncology Investor Conference
08:00am, Wednesday, 07'th Dec 2022
NEWTOWN, Pa., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients
Onconova Therapeutics to Present at the Upcoming RHK Capital Disruptive Growth Conference
08:00am, Monday, 28'th Nov 2022
NEWTOWN, Pa., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients
